Finch Therapeutics receives Nasdaq delisting notice; trading suspended May 28

Finch Therapeutics Group, Inc.

Nasdaq Listing Panel determined to delist Finch; company deemed a 'public shell' without an operating business.
Trading of common stock suspended at opening on May 28, 2024; Nasdaq will file Form 25-NSE after 45 days.
Common stock expected to trade on OTC market, but no assurance of prompt or continued trading.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.